In nine years with Dr. Edison Liu as president and CEO, the Bar Harbor-based Jackson Laboratory has expanded from 1,300 employees to 2,400 at all its sites and has grown its yearly grant funding from $65 million to $108 million last year. JAX ships 3.4 million mice annually to 20,000 laboratories globally.
In 2020, amid dramatically shifting priorities, JAX initiated a large-scale in-vitro fertilization program to produce a COVID-19 mouse colony large enough to meet global demand from treatment and vaccine developers. Liu mobilized senior management to pivot capabilities as a COVID-19 test site, create a high-throughput process for testing specimens, create testing regimes at other organizations, and donate PPE and specimen collection kits. Read more
